TIL (Tumour-Infiltrating Lymphocyte) therapy is a transformative, cell-based immunotherapy approach now entering clinical practice for melanoma. This national summit brings together UK and international leaders to share the science, clinical experience, and infrastructure required to implement TIL therapy safely and effectively. From the biological rationale to real-world delivery, the day explores how academic, clinical, and industry partners can work together…